Dr. Orme is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Division of Medical Oncology
200 1st St SW
Rochester, MN 55905Phone+1 507-255-5123
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2016 - 2019
University of Texas Southwestern Medical SchoolClass of 2016
Certifications & Licensure
MN State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Young Investigator Award Prostate Cancer Foundation, 2022
Clinical Trials
- Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors Start of enrollment: 2021 Apr 01
Publications & Presentations
PubMed
- Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [Lu]Lu-PSMA-617.Miguel Muniz, Oliver Sartor, Jacob J Orme, Regina M Koch, Hana R Rosenow
Journal of Nuclear Medicine. 2024-12-03 - Neurologic Symptoms AfterLu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, Jacob J Orme, Daniel S Childs
Journal of Nuclear Medicine. 2024-09-03 - Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in lethal prostate cancer.Pradeep S Chauhan, Irfan Alahi, Savar Sinha, Elisa M Ledet, Ryan Mueller
Clinical Cancer Research. 2024-08-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
